US Patent 12018298 PH20 polypeptide variants, formulations and uses thereof
Patent 12018298 was granted and assigned to Halozyme, Inc. on June, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12018298 PH20 polypeptide variants, formulations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
